NCT04449614

Brief Summary

Congenital pulmonary malformation in children is a rare abnormality mostly diagnosed before birth during antenatal ultrasound examinations. These lesions may expand to form lung cysts in children, cause recurrent lung infections and has a potential for malignant change. Therefore, surgical removal in childhood is favoured as the treatment of choice. The surgical correction may involve 'open' surgery or 'key hole' surgery. There is, however, a variation in surgical and anaesthetic techniques and timing of this surgery and subsequent complications reported post-surgery. The purpose of this investigation is to review anaesthetic and surgical case notes and the subsequent well-being of all children who underwent lung surgery to remove above lung lesions over the last 10 years (2008-2017) at a regional centre. The aim is to look at the current status of these children in relation to their health, growth and development evaluated via a 20-minute structured telephone interview with prior consent.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2018

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

October 10, 2018

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2019

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2020

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 29, 2020

Completed
Last Updated

June 29, 2020

Status Verified

April 1, 2018

Enrollment Period

1.7 years

First QC Date

October 10, 2018

Last Update Submit

June 23, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Perioperative morbidity associated with the CPAM removal surgical episode

    This will be a descriptive measure of perioperative complications, namely, number including converted to 'open' surgery from thoracoscopy and its reasons, postoperative respiratory complications needing active therapy such as return to theatre, reintubation, insertion of chest drains to manage pneumothorax, haemothorax or chylothorax, duration of intensive care needed and duration of hospital stay needed.

    28 days postoperative

  • Perioperative mortality associated the CPAM removal surgical episode

    This will include 28 day mortality associated with the surgical episode

    28 days postoperative

Secondary Outcomes (2)

  • Post surgery long-term well being as reported by parents/guardian

    A prospective 1 year to complete a telephone follow-up of all participant children who had their surgery performed between 2007-2017

  • Post surgery long-term development and growth of children as reported by parent/guardian

    A prospective 1 year to complete a telephone follow-up of all participant children who had their surgery performed between 2007-2017

Study Arms (1)

1

Inclusion criteria: All consenting Infants and children who have had A Congenital Pulmonary Airway Malformation (CPAM) surgically removed by thoracoscopy over a 10 year period (2008-2017) in a regional centre. Exclusion criteria: Non consenting participants

Procedure: Thoracoscopic CPAM resection

Interventions

Surgical removal of lung lesion

1

Eligibility Criteria

AgeUp to 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

All infants and children who had undergone thoracoscopic surgery for a CPAM from 2008 to 2017 at a regional centre

You may qualify if:

  • All children undergoing surgery for a CPAM removal between 2008 - 2017 at a regional hospital.

You may not qualify if:

  • Lack of informed consent. Inability to contact parents/guardian for the required post-operative interview

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kings College Hospital NHS Trust

London, SE5 9RS, United Kingdom

Location

Related Publications (10)

  • Subramanyam R, Ledbetter K, Fleck R, Mahmoud M. Images in Anesthesiology: Congenital Pulmonary Airway Malformation. Anesthesiology. 2017 Aug;127(2):382. doi: 10.1097/ALN.0000000000001602. No abstract available.

    PMID: 28719530BACKGROUND
  • Cloutier MM, Schaeffer DA, Hight D. Congenital cystic adenomatoid malformation. Chest. 1993 Mar;103(3):761-4. doi: 10.1378/chest.103.3.761.

    PMID: 8449065BACKGROUND
  • Sfakianaki AK, Copel JA. Congenital cystic lesions of the lung: congenital cystic adenomatoid malformation and bronchopulmonary sequestration. Rev Obstet Gynecol. 2012;5(2):85-93.

    PMID: 22866187BACKGROUND
  • Mann S, Wilson RD, Bebbington MW, Adzick NS, Johnson MP. Antenatal diagnosis and management of congenital cystic adenomatoid malformation. Semin Fetal Neonatal Med. 2007 Dec;12(6):477-81. doi: 10.1016/j.siny.2007.06.009. Epub 2007 Oct 22.

    PMID: 17950681BACKGROUND
  • David M, Lamas-Pinheiro R, Henriques-Coelho T. Prenatal and Postnatal Management of Congenital Pulmonary Airway Malformation. Neonatology. 2016;110(2):101-15. doi: 10.1159/000440894. Epub 2016 Apr 13.

    PMID: 27070354BACKGROUND
  • Sueyoshi R, Koga H, Suzuki K, Miyano G, Okawada M, Doi T, Lane GJ, Yamataka A. Surgical intervention for congenital pulmonary airway malformation (CPAM) patients with preoperative pneumonia and abscess formation: "open versus thoracoscopic lobectomy". Pediatr Surg Int. 2016 Apr;32(4):347-51. doi: 10.1007/s00383-015-3848-z. Epub 2015 Dec 12.

  • CH'IN KY, TANG MY. Congenital adenomatoid malformation of one lobe of a lung with general anasarca. Arch Pathol (Chic). 1949 Sep;48(3):221-9. No abstract available.

  • Laberge JM, Flageole H, Pugash D, Khalife S, Blair G, Filiatrault D, Russo P, Lees G, Wilson RD. Outcome of the prenatally diagnosed congenital cystic adenomatoid lung malformation: a Canadian experience. Fetal Diagn Ther. 2001 May-Jun;16(3):178-86. doi: 10.1159/000053905.

  • Kapralik J, Wayne C, Chan E, Nasr A. Surgical versus conservative management of congenital pulmonary airway malformation in children: A systematic review and meta-analysis. J Pediatr Surg. 2016 Mar;51(3):508-12. doi: 10.1016/j.jpedsurg.2015.11.022. Epub 2015 Dec 9.

  • Khan H, Kurup M, Saikia S, Desai A, Mathew M, Sheikh A, Goonasekera CDA. Morbidity after thoracoscopic resection of congenital pulmonary airway malformations (CPAM): single center experience over a decade. Pediatr Surg Int. 2021 May;37(5):549-554. doi: 10.1007/s00383-020-04801-1. Epub 2021 Jan 3.

MeSH Terms

Conditions

Pulmonary Arteriovenous FistulasCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Chulananda Goonasekera

    Consultant Anaesthetist

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 10, 2018

First Posted

June 29, 2020

Study Start

January 10, 2018

Primary Completion

September 30, 2019

Study Completion

February 28, 2020

Last Updated

June 29, 2020

Record last verified: 2018-04

Locations